Cargando…
Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement
BACKGROUND: The aim was to investigate, whether 5,000 IUaXa/day certoparin lowers the incidence of deep vein thrombosis (DVT) in patients undergoing elective hip replacement surgery vs. 3,000 IUaXa/day. Double-blind, multicenter, randomised trial in 500 patients. Primary endpoint: incidence of sympt...
Autores principales: | Bramlage, Peter, Michaelis, Hans-Christoph, Melzer, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441324/ https://www.ncbi.nlm.nih.gov/pubmed/22713698 http://dx.doi.org/10.1186/1477-9560-10-10 |
Ejemplares similares
-
Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease – a post-hoc analysis of the PARAT trial
por: Melzer, Nima, et al.
Publicado: (2014) -
Anti-Xa activities following 5,000 IU and 7,500 IU of s.c. dalteparin in critically ill patients and 5,000 IU in medical patients: a prospective randomized study
por: Heinz, GH, et al.
Publicado: (2013) -
The 3,000 rice genomes project
Publicado: (2014) -
5.000 problemas de análisis matemático
por: Demidovich, B. P. (Boris Pavlovich)
Publicado: (1998) -
Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D(3)
por: Schoenmakers, Inez, et al.
Publicado: (2013)